KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Non-Controlling InterestsInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

National Health Investors (NHI) Operating Income (2016 - 2019)

National Health Investors filings provide 10 years of Operating Income readings, the most recent being $42.8 million for Q3 2019.

  • On a quarterly basis, Operating Income rose 4.33% to $42.8 million in Q3 2019 year-over-year; TTM through Sep 2019 was $159.4 million, a 1.15% increase, with the full-year FY2015 number at $150.3 million, up 45.86% from a year prior.
  • Operating Income hit $42.8 million in Q3 2019 for National Health Investors, up from $40.0 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of $42.8 million in Q3 2019 to a low of $18.6 million in Q2 2016.
  • Median Operating Income over the past 4 years was $38.1 million (2017), compared with a mean of $36.0 million.
  • Biggest five-year swings in Operating Income: surged 106.13% in 2017 and later fell 8.91% in 2019.
  • National Health Investors' Operating Income stood at $33.5 million in 2016, then grew by 18.28% to $39.6 million in 2017, then rose by 3.52% to $41.0 million in 2018, then increased by 4.33% to $42.8 million in 2019.
  • The last three reported values for Operating Income were $42.8 million (Q3 2019), $40.0 million (Q2 2019), and $35.7 million (Q1 2019) per Business Quant data.